Back to results
US 8,912,194 B2Granted
CDK inhibitor for the treatment of mesothelioma
AssigneeNerviano Medical Sciences S.R.L.
InventorsMarina Ciomei, Angela Scaburri
Life of this patent
Estimating the term…
Abstract
The invention provides a low molecular weight ATP-competitive CDK inhibitor for use in the treatment of mesothelioma. The compound can be administered together with one or more cytotoxic or cytostatic agents.
Claims1
A method of treating a malignant mesothelioma comprising administration of a compound of formula (I)
- or a pharmaceutically acceptable salt thereof and administration of one or more cytotoxic or cytostatic chemical agents selected from the group consisting of pemetrexed and a platinum derivative.
Dependencies are inferred from the claim text.